TeraCrystal is a Contract Research Organization, offering a comprehensive range of Solid State, Crystallization and Analytical services. Differentiated by strong scientific focus, we assist the customers, innovators or CDMOs companies, to rapidly and successfully progress their lead compounds into all drug development phases, minimizing the risk of failure at later stages.
We integrate in silico calculations in our studies, the combination of predictive/modelling tools with experimental effort, giving us the opportunity to significantly reduce the screening work and accelerate the delivery time, but more important to optimize the drug candidate selection.
The work performed in TeraCrystal’s laboratories is carried out to the highest possible standard, in the frame of a strict internal quality system complying with cGMP. Our procedures are routinely audited by the customers.
We offer our clients exclusivity and strong IP protection over any the discoveries we make a treat client information as extremely confidential.
We provide our customers a flexible business model, tailored to their needs: fee for service, multi-compounds screening, long-term term service agreement and full time equivalent (FTE)
We have a customer-oriented approach, based on open communication and trust, that allows us to establish long-term relations with our clients.
Summarizing, TeraCrystal’s main competitive strengths are: proficiency in solid state and crystallization, ability to carry out projects on time, skill set, our flexibility and our ability to deliver.